熱門資訊> 正文
Gilead Sciences将2025财年GAAP每股收益指引从5.85 - 6.15美元上调至6.65 - 6.85美元，而Est为5.98美元
2025-10-31 04:03
| GILEAD SCIENCES, INC. | ||||||||
| RECONCILIATION OF GAAP TO NON-GAAP 2025 FULL-YEAR GUIDANCE(1) | ||||||||
| (unaudited) | ||||||||
| (in millions, except percentages and per share amounts) | Provided February 11, 2025 |
Updated April 24, 2025 |
Updated August 7, 2025 |
Updated October 30, 2025 |
||||
| Projected product gross margin GAAP to non-GAAP reconciliation: | ||||||||
| GAAP projected product gross margin | 77.0% - 78.0% | 77.0% - 78.0% | ~ 78.0% | ~ 78.0% | ||||
| Acquisition-related expenses | ~ 8.0% | ~ 8.0% | ~ 8.0% | ~ 8.0% | ||||
| Non-GAAP projected product gross margin | 85.0% - 86.0% | 85.0% - 86.0% | ~ 86.0% | ~ 86.0% | ||||
| Projected operating income GAAP to non-GAAP reconciliation: | ||||||||
| GAAP projected operating income | $10,200 - $10,700 | $10,200 - $10,700 | $10,300 - $10,700 | $10,300 - $10,600 | ||||
| Acquisition-related, IPR&D impairment and restructuring expenses | ~ 2,500 | ~ 2,500 | ~ 2,700 | ~ 2,800 | ||||
| Non-GAAP projected operating income | $12,700 - $13,200 | $12,700 - $13,200 | $13,000 - $13,400 | $13,100 - $13,400 | ||||
| Projected effective tax rate GAAP to non-GAAP reconciliation: | ||||||||
| GAAP projected effective tax rate(2) | ~ 20% | ~ 21% | ~ 21% | ~ 16% | ||||
| Income tax effect of above non-GAAP adjustments and fair value adjustments of equity securities, and discrete and related tax adjustments(2) | (~ 1%) | (~ 2%) | (~ 2%) | ~ 3% | ||||
| Non-GAAP projected effective tax rate | ~ 19% | ~ 19% | ~ 19% | ~ 19% | ||||
| Projected diluted EPS GAAP to non-GAAP reconciliation: | ||||||||
| GAAP projected diluted EPS | $5.95 - $6.35 | $5.65 - $6.05 | $5.85 - $6.15 | $6.65 - $6.85 | ||||
| Acquisition-related, IPR&D impairment and restructuring expenses, fair value adjustments of equity securities and discrete and related tax adjustments(2) | ~ 1.75 | ~ 2.05 | ~ 2.10 | ~ 1.40 | ||||
| Non-GAAP projected diluted EPS | $7.70 - $8.10 | $7.70 - $8.10 | $7.95 - $8.25 | $8.05 - $8.25 | ||||
推薦文章
華盛早報 | 1月再降息？瑞銀稱市場低估其概率；特斯拉大漲超3%創年內新高
華盛早報 | 美聯儲主席人選生變？除了哈塞特，特朗普也支持沃什；AI泡沫論重燃」？甲骨文大跌后緊急迴應
新股申購 | 諾比侃、翰思艾泰-B、輕松健康三隻新股今起招股！
新興市場套利狂潮未止！華爾街看好2026年高收益貨幣前景
詳解美聯儲意外「擴表」，影響幾何？
港股周報 | 定調2026！中央經濟工作會議機構最新解讀來了；中興通訊遭遇重磅利空后，擬至多回購12億元股份
12月13日外盤頭條：特朗普傾向由沃什或哈塞特領導美聯儲 博通暴跌 甲骨文推迟OpenAI部分數據中心工期
一周財經日曆 | 聚焦數據！11月非農就業報告和CPI年率接踵而來；傳日本央行下周加息「板上釘釘」；美光財報出爐
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
